Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers A > Headlines for Antigenics Inc. > News item |
Antigenics files $100 million shelf registration
By Devika Patel
Knoxville, Tenn., May 29 - Antigenics Inc. filed a $100 million shelf registration in an S-3 filing with the Securities and Exchange Commission.
The registration covers warrants, common stock, preferred stock and debt securities. The debt securities and preferreds may be convertible.
Proceeds will be used for general corporate purposes.
Antigenics is a New York-based biotechnology company with a focus on cancers and infectious diseases.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.